Risk Factors Associated with Chronic Kidney Disease In Infants With Posterior Urethral Valve: A Single Center Study of 110 Patients Managed By Valve Ablation And Bladder Neck Incision
1 January 2020
Purpose: Concurrent valve ablation and bladder neck incision is suggested as an effective and safe treatment approach in posterior urethral valve children with prominent bladder neck. We evaluated chronic kidney disease risk factors in these children.
Materials and methods: We retrospectively reviewed medical records of children with posterior urethral valve and included those younger than 18 years old who underwent valve ablation and bladder neck incision at our institution. We recorded patient demographics, presenting symptoms, laboratory and radiographic data. Our primary outcome was chronic kidney disease defined as stage 3 chronic kidney disease or higher. Renal outcome risk factors such as preoperative vesicoureteral reflux and serum creatinine, age at diagnosis, adjuvant urinary diversion were analyzed.
Results: A total of 110 patients met our inclusion criteria. Median age at diagnosis was 10.4 months (range 14 days to 12 years). Prenatal diagnosis in 72.7% was the most common presentation. Mean follow-up duration was 3 years and 12(10.9%) patients progressed to chronic kidney disease. Preoperative serum creatinine greater than one mg/dL was the only factor associated with progression to chronic kidney disease.
Conclusion: In our group of children with posterior urethral valve ablation and bladder neck incision, initial creatinine value of greater than one mg/dL is more probably associated with renal impairment while; vesicoureteral reflux, age at diagnosis, presenting symptoms and adjuvant urinary diversion were not significant prognostic factors. Further randomized controlled evaluations are required to analyze the effects of concurrent valve ablation and bladder neck incision on renal outcome.
- urethral obstruction
- kidney failure
How to Cite
-Hebenstreit D, Csaicsich D, Hebenstreit K, Muller-Sacherer T Berlakovich G, Springer A. Long-term outcome of pediatric renal transplantation in boys with posterior urethral valves. J Pediatr Surg. 2018; 53:2256-60.
-Uthup S, Binitha R, Geetha S, Hema R, Kailas L. A follow-up study of children with posterior urethral valve. Indian J Nephrol. 2010; 20: 72-5.
-Vasconcelos MA, ACS ES, Gomes IR, Carvalho RA, Pinheiro SV, Colosimo EA, et al. A clinical predictive model of chronic kidney disease in children with posterior urethral valves. Pediatr Nephrol. 2019; 34:283-94.
-Engel DL, Pope JC, IV, Adams MC, Brock JW, III, et al. Risk factors associated with chronic kidney disease in patients with posterior urethral valves without prenatal hydronephrosis. J Urol 2011; 185:2502-6.
-Trockman BA, Gerspach J, Dmochowski R, Haab F, Zimmern PE, Leach GE. Primary bladder neck obstruction: urodynamic findings and treatment results in 36 men. J Urol. 1996; 156: 1418-20.
-Androulakakis PA, Karamanolakis DK, Tsahouridis G, Stefanidis AA, Palaeodimos I. Myogenic bladder decompensation in boys with a history of posterior urethral valves is caused by secondary bladder neck obstruction? BJU Int. 2005; 96:140-3.
-Misseri R, Combs AJ, Horowitz M, Donohoe JM, Glassberg KI. Myogenic failure in posterior urethral valve disease: real or imagined? J Urol. 2002; 168(4Pt2): 1844-8.
-Kajbafzadeh AM, Payabvash S, Karimian G. The effects of bladder neck incision on urodynamic abnormalities of children with posterior urethral valves. J Urol. 2007; 178: 2142-9.
-Keihani S, Kajbafzadeh AM, Kameli SM, Abbasioun R. Long-term impacts of concurrent posterior urethral valve ablation and bladder neck incision on urinary continence and ejaculation. J Urol. 2017; 99: 278-80.
-Nasir AA, Ameh EA, Abdur-Rahman LO, Adeniran JO, Abraham MK. Posterior urethral valve. World J Pediatr. 2011; 7: 205-16.
-Farhat W, McLorie G, Capolicchio G, Khoury A, Bagli D, Merguerian PA. Outcomes of primary valve ablation versus urinary tract diversion in patients with posterior urethral valves. Urology. 2000; 56: 653-7.
-Jaureguizar E, Lopez Pereira P,Martinez Urrutia MJ,Espinosa L, LobatoR. Does neonatal pyeloureterostomy worsen bladder function in children with posterior urethral valves? J Urol. 2000; 164(3 Pt 2): 1031-3.
-Tayib AM, Alsayyad AJ. Management of obstructive uropathy with cutaneous ureterostomy in posterior urethral valve. Saudi J Kidney Dis Transpl. 2012; 23: 355-7.
-Heikkila J, Holmberg C, Kyllonen L, Rintala R, Taskinen S. Long-term risk of end stage renal disease in patients with posterior urethral valves. J Urol. 2011;186: 2392-6.
-Close CE, Carr MC, Burns MW, Mitchell ME. Lower urinary tracr changes after early valve ablation in neonates and infants: Is early diversion warranted? J Urol. 1997; 157: 984-8.
-Ghanem MA, Nijman RJ. Long-term followup of bilateral high (sober) urinary diversion in patients with posterior urethral valves and its effect on bladder function. J Urol. 2005; 173: 1721-4.
-Akdogan B, Dogan HS, Keskin S, Burgu B, Tekgul S. Significance of age-specific creatinine levels at presentation in posterior urethral valve patients. J Pediatr Urol. 2006; 2: 446-52.
-Chua ME, Ming JM, Carter S, ElHout Y, Koyle MA, Noone D, et al. Impact of adjuvant urinary diversion versus valve ablation alone on progression from chronic to end stage renal disease in posterior urethral valves: A single institution 15-year time-to-event analysis.J Urol. 2018;199:824-30.
-Sarhan O, Zaccaria I, Maacher MA, Muller F, Vuillard E, Delezoide AL, et al. Long-term outcome of prenatally detected posterior urethral valves: single center study of 65 cases managed by primary valve ablation. J Urol. 2008; 179(1): 307-12.
-Ziylan O, Oktar T, Ander H, Korgali E, Rodoplu H, Kocak T. The impact of late presentation of posterior urethral valves on bladder and renal function. J Urol. 2006; 175(5): 1894-7.
-Hutton KA, Thomas DF, Irving HC, Arthur RJ, Smith SEW. Prenatal detection of posterior urethral valves: Is gestational age at detection a predictor of outcome? J Urol. 1994; 152: 698-701.
-Kibar Y, Ashley RA, Roth CC, Frimberger D, Kropp BP. Timing of posterior urethral valve diagnosis and its impact on clinical outcome. J Pediatr Urol. 2011; 7:538-42.
-Sarhan O, El-Dahshan K, Sarhan M. Prognostic value of serum creatinine levels in children with posterior urethral valves treated by primary valve ablation. J Pediatr Urol. 2010; 6: 11-4.
-Ansari MS, Gulia A, Srivastava A, Kapoor R. Risk factors for progression to end- stage renal disease in children with posterior urethral valves. J Pediatr Urol. 2010; 6: 261-4.
-Otukesh H, Sharifiaghdas F, Hoseini R, Fereshtehnejad SM, Rabiee N, Kiaiee MF, et al. Long-term upper and lower urinary tract functions in children with posterior urethral valves. J Pediatr Urol. 2010; 6: 143-7.
-Nickavar A, Otoukesh H, Sotoudeh K. Validation of initial serum creatinine as a predictive factor for development of end stage renal disease in posterior urethral valves. Ind J Pediatr. 2008; 75:695-7.
-Nimako B, Lazarus J, Dewan P, Nourse P, Gajjar P. Are early prognostic indicators reliable in posterior urethral valves management? African J Urol.2018; 24:243-7.
-Lopez Pereira P, Martinez Urrutina MJ, Espinosa L, Lobato R, Navarro M, Jaureguizar E. Bladder dysfunction as a prognostic factor in patients with posterior urethral valves. BJU Int. 2002; 90:308-11.
-Puri P, Kumar R. Endoscopic correction of vesicoureteric reflux secondary to posterior urethral valves. J Urol. 1996; 156; 680-682.
-Sarhan OM, El-Ghoneimi AA, Helmy TE, Dawaba MS, Ghali AM, Ibrahiem el-HI. Posterior urethral valves: Multivariate analysis of factors affecting the final renal outcome. J Urol. 2011; 185: 2491-5.
- Abstract Viewed: 0 times
- Just Accepted/6038 Downloaded: 0 times